Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBA-P01 Phase 2 Trial for Lateral Canthal Lines
NCT04143854Phase 2Completed
- Sponsor
- Medytox Inc.
- Start
- May 2019
- Primary completion
- Aug 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fluorometholone acetate in lateral canthal rhytides (3 arms), sponsored by Medytox Inc. Primary endpoint: Facial Wrinkle Scale Change at 4 weeks. Started May 2019; status: completed.
02
Drugs
fluorometholone acetate
03
Conditions
lateral canthal rhytides
Beyond the preview
Go deeper on NCT04143854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04143854.